The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Risk factors and recurrent thrombosis in primary antiphospholipid syndrome”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2025 |
Ewa Haladyj, Barbara Stypinska, Agata Matusiewicz, Wojciech Kunisz, Marzena Olesinska, Agnieszka Paradowska-Gorycka. Damage Burden in Polish Patients with Antiphospholipid Syndrome Measured Using Damage Index for Antiphospholipid Syndrome (DIAPS), Biomedicines. 2025; 13: 1671. https://doi.org/10.3390/biomedicines13071671 |
|
2 |
2025 |
Flavio Signorelli, Gustavo Guimarães Moreira Balbi, Vinícius Pereira Bastos, Thaiana Reis-Carvalho, Evandro Mendes Klumb, Roger Abramino Levy. 2025; https://doi.org/10.2139/ssrn.5414253 |
|
3 |
2025 |
Flavio Signorelli, Gustavo Guimarães Moreira Balbi, Vinícius Pereira Bastos, Thaiana Reis-Carvalho, Evandro Mendes Klumb, Roger Abramino Levy. Recurrent Thrombosis and Hemorrhagic events in a Large Single-center Primary Antiphospholipid Syndrome Cohort: Results from APS-Rio Cohort After Nearly 1,000 Patients-year of Follow-up, Seminars in Arthritis and Rheumatism. 2025; 152873152873. https://doi.org/10.1016/j.semarthrit.2025.152873 |
|
4 |
2024 |
Tatiana M. Reshetnyak, Fariza A. Cheldieva, Svetlana I. Glukhova, Kamila S. Nurbaeva, Nataliya V. Seredavkina, Mariya V. Cherkasova, Alexander M. Lila, Evgeny L. Nasonov. Thrombotic antiphospholipid syndrome: Recurrent thromboses, Rheumatology Science and Practice. 2024; 62: 408. https://doi.org/10.47360/1995-4484-2024-408-417 |
|
5 |
2025 |
T. M. Reshetnyak, F. A. Cheldieva, S. I. Glukhova, K. S. Nurbaeva, N. V. Seredavkina, M. V. Cherkasova, A. M. Lila, E. L. Nasonov. Thrombotic Antiphospholipid Syndrome: Recurrent Thromboses, Doklady Biochemistry and Biophysics. 2025; 522: 375. https://doi.org/10.1134/S1607672925700152 |